Tuesday, June 18, 2024
More
    HomeFinance"New Affordable UI Drug Available in Indian Market through MSN Group: Originally...

    “New Affordable UI Drug Available in Indian Market through MSN Group: Originally Valued at `1,233, Now Offered for `27”

    Related stories

    Jitesh V, Collector, meets District Chief Justice Patil Vasanth

    The new Collector Jitesh V. warmly welcomed the Principal...

    MLA’s Potential Move to Congress Shakes Up Gadwal Politics

    The recent political developments in Gadwal, particularly involving MLA...

    Pawan Kalyan to assume charge on June 19 after meeting with Chandrababu Naidu at AP secretariat

    Deputy Chief Minister Pawan Kalyan met Chief Minister N. Chandrababu Naidu at the State Secretariat on June 18, 2024 for the first time after the formation of the coalition Government.

    The Indian pharmaceutical company MSN Group has recently launched a new affordable drug for the treatment of ulcerative colitis, a chronic inflammatory bowel disease. The drug, called mesalamine, was originally priced at `1,233 but is now being offered for only `27, making it significantly more accessible to patients in need.

    Ulcerative colitis is a condition that affects the large intestine, causing inflammation and ulcers in the lining of the colon. It can cause a range of symptoms including abdominal pain, diarrhea, and rectal bleeding. While there is no cure for ulcerative colitis, medication can help manage symptoms and prevent complications.

    - Advertisement -

    Mesalamine is a commonly used medication for the treatment of ulcerative colitis. It works by reducing inflammation in the colon, which can help alleviate symptoms and prevent flare-ups. However, the high cost of mesalamine has made it difficult for many patients to access this important medication.

    The launch of MSN Group’s affordable mesalamine is a significant development for patients in India who are living with ulcerative colitis. By offering the drug at such a low cost, MSN Group is helping to ensure that more people can access the treatment they need to manage their condition.

    - Advertisement -

    It’s worth noting that the lower price of MSN Group’s mesalamine does not mean that the drug is of lower quality or less effective than other mesalamine products on the market. The company has stated that their mesalamine is manufactured to the same high standards as other mesalamine products and has undergone rigorous testing to ensure its safety and effectiveness.

    The launch of MSN Group’s affordable mesalamine is also an important step towards making healthcare more accessible and affordable for all. In India, many people struggle to access essential medications due to high costs and limited availability. By offering an affordable alternative to mesalamine, MSN Group is helping to address this issue and improve access to healthcare for all.

    - Advertisement -

    In conclusion, the launch of MSN Group’s affordable mesalamine is a positive development for patients with ulcerative colitis in India. By offering this important medication at a significantly lower cost, MSN Group is helping to improve access to healthcare and ensure that more people can receive the treatment they need to manage their condition. This is a step towards making healthcare more accessible and affordable for all, which is something we should all strive towards.

    - Advertisement -
    Rajesh M
    Rajesh Mhttps://www.telanganatribune.com
    Latest News from Hyderabad, Telangana, India & World!

    Follow us

    3,565FansLike
    179FollowersFollow
    1,202FollowersFollow
    965SubscribersSubscribe

    Contribute News

    You can contribute an article to Telangana Tribune by dropping a mail at newsdesk@telanganatribune.com

    Latest stories

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here